NEW YORK (GenomeWeb News) - NimbleGen has filed for an initial public offering with the Securities and Exchange Commission, the company said Friday.
The number and prices of shares have not yet been determined.
NimbleGen is a microarray developer that specializes in products and services for comparative genomic hybridization, chromatin immunoprecipitation arrays, comparative genome sequencing, and expression analysis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.